Infratil has this morning released the presentation material for its annual Investor Day. Presentations will be recorded during the day and will be available to view on https://infratil.com/for-investors/reports-results-meetings-investor-days/ after the event.
Infratil's objective is to keep its stakeholders well informed about how its businesses are performing and how their delivery of strategic objectives is progressing.
Management will provide an update on Infratil's portfolio strategy, as well as providing views on the near-term outlook. There will also be a number of presentations from senior executives at Infratil’s portfolio businesses, including Qscan Group, RHCNZ Medical Imaging, Longroad Energy, CDC Data Centres, and Vodafone (One NZ).
Infratil has also narrowed its Proportionate EBITDAF guidance range for the year ended 31 March 2023 to $520 million to $535 million (previously $510 to $540 million).
Any enquiries should be directed to:
Any investor enquiries should be directed to:
Mark Flesher
Investor Relations
Email: mark.flesher@infratil.com
- 1. Infratil Investor Day 2023 - Portfolio Update & Outlook (PDF, 1.88MB)
- 2. Infratil Investor Day 2023 - Sector Overviews (PDF, 2.36MB)
- 3. Infratil Investor Day 2023 - CDC Data Centres Update (PDF, 1.13MB)
- 4. Infratil Investor Day 2023 - Longroad Energy Update (PDF, 3.14MB)
- 5. Infratil Investor Day 2023 - Manawa Energy Update (PDF, 1.48MB)
- 6. Infratil Investor Day 2023 - Qscan Group Update (PDF, 1.39MB)
- 7. Infratil Investor Day 2023 - RetireAustralia Update (PDF, 416.85KB)
- 8. Infratil Investor Day 2023 - RHCNZ Medical Imaging Update (PDF, 765.76KB)
- 9. Infratil Investor Day 2023 - Vodafone Update (PDF, 1.42MB)
- 10. Infratil Investor Day 2023 - Wellington Airport Update (PDF, 1.27MB)
Related
Infratil Independent Valuation Update - 31 December 2025
Infratil Independent Valuation Update – 31 December 2025 Attached is an update on the independent valuations completed for three of Infratil’s portfolio companies as at 31 December 2025. Using the
Infratil Newsletter - February 2026
Attached is a copy of the latest Infratil Newsletter for investors. It includes commentary on progress at various portfolio companies and confirms completion of the sale process for two previously
CDC Independent Valuation - 31 December 2025
CDC Independent Valuation – 31 December 2025 CDC’s valuation increased in the quarter, supported by an additional 40MW of previously announced contracted capacity, the addition of 196MW of built operating